Though NEPC can rarely arise de novo, more commonly, it arises from adenocarcinoma in response to selection pressure for AR-independent cells from treatment with AR signaling inhibitors via lineage plasticity and NE differentiation[3,4]. This evidence concerns the gene AR and adenocarcinoma.